RxDoctor Payments Data

Ira Hofer, MD

Anesthesiology · New York, NYNPI 1649593484

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,279 of the $5,290 with a category attached, or 99.8%. Merck accounts for 91.5% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2022 at $2,886 and has fallen 51.4% since, to $1,404 in 2023. Among anesthesiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,290in general payments, 2019–2025

Across 12 payments — averaging $440.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$5K
  • Edwards Lifesciences$450
$120,797in research payments, 2019–2025

Across 3 payments — averaging $40,266 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$121K

What the payments were for

  • Consulting fees$5,279100%
  • Education$110%

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck11$4,840
Edwards Lifesciences1$450

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,290 in reported general payments places this provider in the 95th percentile of 4,157 anesthesiology providers in New York.

See all anesthesiology providers in New York

Medicare billing

Part B allowed, 2024
$9,865
Medicare patients
31
Services billed
37

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →